Mark A. Smith
2019
In 2019, Mark A. Smith earned a total compensation of $622.4K as Chief Medical Officer at Vistagen Therapeutics.
Compensation breakdown
| Bonus | $73,444 |
|---|---|
| Option Awards | $154,922 |
| Salary | $393,991 |
| Total | $622,357 |
Smith received $394K in salary, accounting for 63% of the total pay in 2019.
Smith also received $73.4K in bonus and $154.9K in option awards.
Rankings
In 2019, Mark A. Smith's compensation ranked 11,092nd out of 13,971 executives tracked by ExecPay. In other words, Smith earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,092 out of 13,971 | 21st |
Division Manufacturing | 4,488 out of 5,695 | 21st |
Major group Chemicals And Allied Products | 1,759 out of 2,194 | 20th |
Industry group Drugs | 1,513 out of 1,880 | 20th |
Industry Pharmaceutical Preparations | 1,119 out of 1,392 | 20th |
Source: SEC filing on July 27, 2020.
Smith's colleagues
We found four more compensation records of executives who worked with Mark A. Smith at Vistagen Therapeutics in 2019.